Livzon Pharmaceutical Group reports June 2025 securities changes

Livzon Pharmaceutical Group (SZSE:000513) released its monthly report on securities changes for June 2025, reporting no changes in its issued share capital. As of June 30, 2025, the company's registered share capital remained at CNY 299,807,117 for H shares and CNY 604,293,313 for A shares, totaling CNY 904,100,430. The number of issued shares is 299,807,117 for H shares and 604,293,313 for A shares. Additionally, -11,318,855 A shares were redeemed/repurchased. The report, submitted to the Hong Kong Stock Exchange, confirms compliance with relevant listing rules and regulations and was authorized by the board of directors.